Nerve Cap News Today

Axogen announced positive topline results from a clinical study evaluating its Axoguard Nerve Cap. 

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Axogen Sponsored REPOSE℠ Study Completes Pilot Phase Analysis Axogen, Inc.February 18, 2021 GMT ALACHUA, Fla., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced completion of pilot phase analysis for its REPOSE clinical study.  Analysis of the REPOS...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Axogen, Inc. to Report Fourth Quarter and Full-Year 2020 Financial Results and Host Conference ... Axogen, Inc.February 1, 2021 GMT ALACHUA, Fla., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today confirmed that it will report fourth quarter and full-year 2020 fi...

Axogen Sponsors Donate Life at 2021 Virtual Rose Parade Celebration ALACHUA, Fla., Dec. 23, 2020 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, announced today their sponsorship of Donate Life at the annual Tournament of Roses ® celebration. For 2021, the Rose Parade will be held as a televised special in Pasadena, CA on New Year’s Day. This year’s Donate Life Rose P...